Dittberner U, Eisenbrand G, Zankl H
Department of Human Biology and Human Genetics, University of Kaiserslautern, Federal Republic of Germany.
J Cancer Res Clin Oncol. 1988;114(6):575-8. doi: 10.1007/BF00398179.
The mutagenicity of N-nitrosodiethanolamine (NDELA) and NDELA monoacetate was tested in vitro on lymphocytes of two healthy probands by determining the frequencies of chromosome aberrations, micronuclei and sister chromatid exchanges (SCE). A dose-dependent increase was found in all three test systems for NDELA as well as its monoacetate. The SCE test proved to be most sensitive for the genotoxic effect of NDELA because the differences to the control cultures had already become significant at 250-625 mumol/culture (26.6-65.4 mM). However, NDELA monoacetate showed a higher reactivity in the micronuclei and chromosome aberration test: significantly increased values were found even at 12.5 mumol (1.3 mM), whereas in the SCE test the differences became significant at the 25-mumol (2.7 mM) level. NDELA caused significantly increased rates of micronuclei and chromosome aberrations only at the highest test levels (625-1250 mumol; 65.4-127.6 mM). The results indicate important differences in the genotoxic effects of the two compounds, which might be explained by different lipophilicity and/or special activation processes.
通过测定染色体畸变、微核和姐妹染色单体交换(SCE)的频率,在体外对两名健康受试者的淋巴细胞进行了N - 亚硝基二乙醇胺(NDELA)及其单乙酸酯的致突变性测试。在NDELA及其单乙酸酯的所有三个测试系统中均发现了剂量依赖性增加。SCE测试被证明对NDELA的遗传毒性作用最为敏感,因为在250 - 625 μmol/培养物(26.6 - 65.4 mM)时与对照培养物的差异就已变得显著。然而,NDELA单乙酸酯在微核和染色体畸变测试中表现出更高的反应性:即使在12.5 μmol(1.3 mM)时也发现值显著增加,而在SCE测试中,差异在25 μmol(2.7 mM)水平时变得显著。NDELA仅在最高测试水平(625 - 1250 μmol;65.4 - 127.6 mM)时导致微核率和染色体畸变率显著增加。结果表明这两种化合物的遗传毒性作用存在重要差异,这可能由不同的亲脂性和/或特殊的活化过程来解释。